ISSN : 0970 - 020X, ONLINE ISSN : 2231-5039
     FacebookTwitterLinkedinMendeley

Viscosity and Density Studies of Drugs in Aqueous Solution and in Aqueous Threonine Solution at 298.15 K

Hanaa G. Attiya, Zainab A. H. Al-Dulaimy, Kawther Ahmed Sadiq and Maida Hameed Saleem

 

Department of Chemistry, College of Education for Pure Science-Ibn-Al-Haitham, University of Baghdad- Baghdad, Iraq.

Corresponding Author E-mail: zainabaldialamy@yahoo.com

DOI : http://dx.doi.org/10.13005/ojc/350141

Article Publishing History
Article Received on : 25-10-2018
Article Accepted on : 30-11-2018
Article Published : 18 Jan 2019
Article Metrics
ABSTRACT:

Viscosities (η) and densities (ρ) of atenolol and propranolol hydrochloride in water and in concentrations (0.05 M) and (0.1 M) aqueous solution of threonine have been used to reform different important thermodynamic parameters like apparent molal volumes ϕv, partial molal volumes at infinite dilution ϕ, transfer volume ϕ(tr), the slop Sv, Gibbs free energy of activation for viscous flow of solution ΔG*1,2 and the B-coefficient have been calculated using Jones-Dole equation. These thermodynamic parameters have been predicted in terms of solute-solute and solute-solvent interaction.

KEYWORDS:

Atenolol; Density; L-Threonine; Propranolol Hydrochloride; Viscosity

Download this article as: 

Copy the following to cite this article:

Attiya H. G, Al-Dulaimy Z. A. H, Sadiq K. A, Saleem M. H. Viscosity and Density Studies of Drugs in Aqueous Solution and in Aqueous Threonine Solution at 298.15 K. Orient J Chem 2019;35(1).


Copy the following to cite this URL:

Attiya H. G, Al-Dulaimy Z. A. H, Sadiq K. A, Saleem M. H. Viscosity and Density Studies of Drugs in Aqueous Solution and in Aqueous Threonine Solution at 298.15 K. Orient J Chem 2019;35(1). Available from: https://bit.ly/2Bo1Rbu


Introduction

Drug work in human body is known as pharmacodynamics. The efficiency of a drug depends on its bioavailability.1 The general reason of low oral bioavailability is due to low solubility of drug molecules. Sometimes, low aqueous soluble drugs require high dosages for the coveted action. Low water solubility of drugs is a serious problem for generic developments. Solubility of most drugs is having poor aqueous. Therefore, the raise of drug solubility and its oral bioavailability is a difficult function for drug evaluation process. Sometimes, some carrier molecules are added to the drugs to increase the solubility.2 Numerous of works related to volumetric and viscometric properties of drugs have been completed by many researchers.3-5 Molecular interaction (solute-solute and solute-solvent) have great importance in physical chemistry and geochemistry. Viscosity B-coefficient, partial molar volumes and apparent molar volumes are advantageous in understanding solute-solvent interactions.6,7 L-Threonine (abbreviated as Thr.) distributing polar amino acid, is an essential a-amino acids. It was discovered at last of 20 common proteinogenic amino acids with two chiral centers. 4-(2-hydroxy-3-[(1-methylethyl) amino]propoxy)benzeneacetamide is known chemically as atenolol (ATN),8 is a β1-selective (cavdio selective) adrenorecepter discount drug used for antiangina therapy to relive symptoms, get better indulgence, and an antiarrhythmic to useful check heartbeat and infections. Atenolol is also used in management of alcohol with drawl, in worry states, headache prophylaxis, increased of metabolism, and tremble.9 The drug is formal in Indian pharmacopoeia.10 Isopropyl amino-3-(1-naphthyloxy) propan-2-ol hydrochloride, is known chemically propranolol hydrochloride, is a widely used non-cardio selective beta-adrenergic antagonist and been used for myocardial infarction, arrhythmia, angina pectoris, hypertension, migraine and anxiety.11 Threonine a polar side chains and exhibits good solubility in water, the nature of solute-solute and solute-solvent interactions have been discussed in terms of the values of ϕv,  ϕ, Sv and B-coefficient. Thermodynamic parameters play an important role in detecting the various types of interactions occurring in solution. These are useful in illustrating the nature and effect of solute in solvent, intermolecular interactions and permeation of drug across biological membranes.

 Scheme 1

Scheme 1

Click here to view scheme

Experimental

Amino acid L-threonine obtained from Fluka company is stock solution and used without any further treatment. Atenolol and propranolol hydrochloride were supplied by the state company for drugs industry were medical appliances Samarra Iraq. The viscosity (η) was determined using assuspended-level ubbelohode viscometer described by findly, in a bath controlled to ∓ 0.01 K for all measurements. Vibrating tube with digital anton parr densimeter (DMA 60 / 602) according to Shukla et al. in a thermostated bath controlled to ∓ 0.01 K used to measure densities for all solution.

Result and Discussion

The apparent molal volume (ϕv) is calculated using the following equation.12,13,14

Equation 1

Where and ρ˳ are the densities of solution and solvent respectively, M is molecular weight of solute and (m) is the molality of solution, m is calculated using the following relation:

Equation 2

Where (C) is the molar concentration. As the plots of ϕv against the molal concentration (m) were linear in the studied concentration range, standard partial molar volume ϕv̊ was obtained from the Masson equation.15

ϕ= ϕ+ Sv,m ………. (3)

Where ϕ is the partial molal volume at infinite dilution which gives information about solute hydrophobicity also a measure of solute-solvent interaction. Sv is slop indicating solute-solute interaction. The Gibbs free energy of activation for viscous flow of solution at a given temperature and composition was measure by basing transition theory is given by equation.16

Equation 4

Where h is planks constant, NA is Avogadro’s number, R is the gas constant and T is the absolute temperature. Volume of mole solution, ⊽1,2 obtained from the following relation.

Equation 5

Where M2 and M1 are the molecular weight for solute and solvent respectively.

The viscosity measurements have been analyzed in terms of Jones-Dole equation.17

Equation 6

Where η and η˳ are the viscosities of solution and solvent respectively and C is the molarity of solution, using Jones-Dole equation, was calculated viscosity B-coefficients. The value of B depends upon the nature of solute-solvent interaction which is specific for solute-solvent system and the size of solute. The standard partial molar volume of transfer was obtained from the following relation.18

ϕ (tr)= ϕ (in aqueous threonine)- ϕ (in water) ………. (7)

The values of ϕv̊ (tr) and Sv are listed in Table 7 and 8. The values of ϕ (tr) of drugs in mixed liquids (threonine + water) are higher than those in aqueous solution, ϕ (tr) are positive for all solutions studied and Sv are positive which indicates ion-ion interaction is greater than post-micellar region. The B-coefficients measure the shape effects, the size as well as the structural effect induced by solute-solvent interaction. It can be seen from Tables (1-6) that all the viscosity B-coefficients for drugs are positive, this may be understanding in expressing of the solute-solvent interaction.

Table 1: Molarity, molality, density, viscosity, apparent molal volume, Gibbs free energy of activation for viscous flow, relative viscosity and parameters of Jones-Dole coefficients of atenolol in aqueous solution at 298.15 K.

C(mol. L-1) M(mol. Kg-1) ρ(gm. cm-3) η (cp) ϕv(cm3. mol-1) ΔG*(J. mol-1) ηr Jones-Dole B-coefficient
0.0000 0.0000 0.99705 0.89039 2.7846
0.005 0.0050198 0.99733 0.95941 200.89778 61005 1.07752
0.006 0.0060244 0.99744 0.962627 201.90081 61014 1.08113
0.007 0.0070308 0.99750 0.969056 202.61638

61031

1.08835
0.008 0.0080368 0.99755 0.97455 204.406406

61045

1.09452
0.009 0.0090435 0.99759 0.97874 206.91372

61057

1.09923
0.01 0.0100506 0.99763 0.98042 208.919201

61061

1.10111
0.02 0.020038 0.99810 1.00655 214.15282 61131 1.13046
0.03 0.030290 0.99843 1.031864 220.9535

61198

1.15889
0.04 0.040492 0.99857 1.05174 228.97696

61252

1.18121
0.05 0.050744 0.99865 1.07546 234.99362

61313

1.20785

Table 2: Molarity, molality, density, viscosity, apparent molal volume, Gibbs free energy of activation for viscous flow, relative viscosity and parameters of Jones-Dole coefficients of propranolol hydrochloride in aqueous solution at 298.15 K.

C (mol. L-1) M (mol. Kg-1) ρ (gm. cm-3) η (cp) ϕv (cm3. mol-1) ΔG* (J. mol-1) ηr Jones-DoleB-coefficient
0.0000 0.0000 0.99705 0.89039 3.5047
0.005 0.0050204 0.99742 1.03175 224.96221 61186 1.15876
0.006 0.0060259 0.99748 1.034838 224.80140 61194 1.16223
0.007 0.007032 0.99755 1.044810 225.04145

61218

1.173430
0.008 0.0080382 0.99761 1.051738 226.47684

61235

1.18121
0.009 0.009045 0.99767 1.05554 227.58442

61244

1.18548
0.01 0.0100527 0.99772 1.058166 229.48006

61251

1.18843
0.02 0.020155 0.99823 1.089348 237.50229 61329 1.22345
0.03 0.0300420 0.99859 1.1144481 244.73276

61391

1.25164
0.04 0.040535 0.99864 1.150704 256.80856

61477

1.29236
0.05 0.05082 0.99872 1.179206 263.17909

61545

1.32437

Table 3: Molarity, molality, density, viscosity, apparent molal volume, Gibbs free energy of activation for viscous flow, relative viscosity and parameters of Jones – Dole coefficients of atenolol in (0.05 M) aqueous solution of threonine at 298.15 K.

C (mol. L-1) M (mol. Kg-1) ρ (gm. cm-3) η(cp) ϕv (cm3. mol-1) ΔG* (J. mol-1) ηr Jones-DoleB-coefficient
0.0000 0.0000 1.01235 1.09357 0.1674
0.1 0.10333

1.01348

1.29517 251.8892 66137 1.18435
0.2 0.20806

1.01450

1.31952

252.4325

66217

1.206623
0.3 0.32069

1.01537

1.34275

253.1074

66295

1.2278651
0.4 0.43981

1.01602

1.37257

253.9881

66386

1.25513
0.5 0.56588

1.01673

1.38865

254.3983

66455

1.26983
0.6 0.699904

1.01704

1.41917

255.3299

66544

1.29774
0.7 0.84296

1.01726

1.43745

256.1226

66614

1.31446
0.8 0.99473

1.01728

1.46028

256.9640

66694

1.33533
0.9 1.15735

1.01731

1.49297

257.6075

66789

1.36523
1.0 1.33147

1.01735

1.50993

258.1123

66859

1.38073

Table 4: Molarity, molality, density, viscosity, apparent molal volume, Gibbs free energy of activation for viscous flow, relative viscosity and parameters of Jones – Dole coefficients of atenolol in (0.1 M) aqueous solution of threonine at 298.15 K.

C (mol. L-1) M (mol. Kg-1) ρ (gm. cm-3) η(cp) ϕv (cm3. mol-1) ΔG* (J. mol-1) ηr Jones-DoleB-coefficient
0.0000 0.0000 1.01458 1.10257 0.1759
0.1 0.10115

1.01525

1.31328 255.86944 66167 1.19111
0.2 0.20777

1.01591

1.33693

256.26352

66246

1.21256
0.3 0.32034

1.01639

1.35863

256.52647

66322

1.23224
0.4 0.43941

1.01684

1.38817

256.90440

66412

1.25904
0.5 0.565572

1.01721

1.40025

257.2887

66435

1.26999
0.6 0.69971

1.01728

1.42731

258.0379

66557

1.29453
0.7 0.84246

1.01731

1.45057

258.62898

66637

1.31563
0.8 0.99468

1.01732

1.47854

259.09737

66724

1.34099
0.9 1.157303

1.01733

1.52403

259.4657

66840

1.38225
1.0 1.331434

1.01735

1.55954

259.9546

66939

1.41446

Table 5: Molarity, molality, density, viscosity, apparent molal volume, Gibbs free energy of activation for viscous flow, relative viscosity and parameters of Jones – Dole coefficients of propranolol hydrochloride in (0.05 M) aqueous solution of threonine at 298 .15 K.

C (mol. L-1) M (mol. Kg-1) ρ (gm. cm-3) η(cp) ϕv (cm3. mol-1) ΔG* (J. mol-1) ηr Jones-DoleB-coefficient
0.0000 0.0000 1.01674 1.11425 0.2137
0.1 0.100985

1.01983

1.33918 260.53875 65943 1.20187
0.2 0.207551

1.02278

1.36556

261.227123

66078

1.22554
0.3 0.320202

1.02565

1.40066

261.72403

66128

1.25704
0.4 0.439614

1.02821

1.41347

262.727004

66184

1.26854
0.5 0.56655

1.03044

1.45717

263.98106

66305

1.30776
0.6 0.70165

1.03261

1.49320

264.91539

66407

1.34009
0.7 0.84589

1.03459

1.50444

265.84971

66468

1.35018
0.8 0.999713

1.03641

1.56044

266.5829

66598

1.40044
0.9 1.165999

1.03809

1.58841

267.60016

66691

1.42554
1.0 1.34447

1.03959

1.64204

268.45699

66819

1.47367

Table 6: Molarity, molality, density, viscosity, apparent molal volume, Gibbs free energy of activation for viscous flow, relative viscosity and parameters of Jones-Dole coefficients of propranolol hydrochloride in (0.1M) aqueous solution of threonine at 298.15 K.

C (mol. L-1) M (mol. kg-1) ρ (gm. cm-3) η(cp) ϕv (cm3. mol-1) ΔG* (J. mol-1) ηr Jones-DoleB-coefficient
0.0000 0.0000 1.01824 1.13057 0.2321
0.1 0.10089

1.02071

1.39121 266.24253 65999 1.23054
0.2 0.20749

1.02305

1.40741

266.88177

66066

1.24487
0.3 0.32037

1.02515

1.43717

267.88028

66157

1.27119
0.4 0.44019

1.02701

1.46598

268.96920

66247

1.29667
0.5 0.56767

1.02869

1.49854

269.97606

66343

1.32547
0.6 0.70371

1.03011

1.52109

271.07243

66424

1.34542
0.7 0.84935

1.03122

1.60653

272.27648

66646

1.42099
0.8 0.99446

1.03221

1.63930

273.35163

66697

1.44998
0.9 1.173617

1.03308

1.67062

274.30782

66794

1.47768
1.0 1.356134

1.03319

1.69098

275.81896

66903

1.49569

Table 7: Limiting, partial molal volume, slop and partial molal volume of transfer at infinite dilution of atenolol at 298.15 K.

Conc. ϕ Sv ϕ (tr) (cm3. mol-1)
0% 198.8 732.13
0.05 M 251.48 5.2735 52.68
0.1 M 255.49 3.467 56.68

Table 8: Limiting, partial molal volume, slop and partial molal volume of transfer at infinite dilution of propranolol hydrochloride at 298.15 K.

Conc. ϕ Sv ϕ (tr)  (cm3. mol-1)
0% 219.32 881.41
0.05 M 259.94 6.6078 40.62
0.1 M 265.49 7.7197 46.17
 Figure 1: plots of ϕv versus (m) for (⬛) propranolol hydrochloride and (◊) atenolol in aqueous solution at 298.15 K.

Figure 1: plots of ϕv versus (m) for (⬛) propranolol hydrochloride and (◊) atenolol in aqueous solution at 298.15 K.

Click here to view figure

 Figure 2: plots of ϕv versus (m) for (X) propranolol hydrochloride , (⬛)  atenolol in 0.05 M threonine and (◊) propranolol hydrochloride, (Δ) atenolol in 0.1 M threonine  at 298.15 K.

Figure 2: plots of ϕv versus (m) for (X) propranolol hydrochloride, (⬛) atenolol in 0.05 M threonine and () propranolol hydrochloride, (Δ) atenolol in 0.1 M threonine  at 298.15 K.

Click here to view figure

 Figure 3: plots of ηr versus (c) for (◊) propranolol hydrochloride and (⬛) atenolol in aqueous solution at 298.15 K.

Figure 3: plots of ηr versus (c) for () propranolol hydrochloride and (⬛) atenolol in aqueous solution at 298.15 K.

Click here to view figure

 Figure 4: plots of  ηr versus (c) for (X) propranolol hydrochloride, (Δ) atenolol in 0.05 M threonine and (◊) propranolol hydrochloride, (⬛)   atenolol in 0.1 M threonine  at 298.15 K Figure 4: plots of  ηr versus (c) for (X) propranolol hydrochloride, (Δ) atenolol in 0.05 M threonine and () propranolol hydrochloride, (⬛) atenolol in 0.1 M threonine  at 298.15 K.

Click here to view figure

Conclusion

The density and viscosity of atenolol and propranolol hydrochloride in water and in concentrations (0.05 M and 0.1 M) aqueous solution of threonine are measured. Different thermodynamics parameters such as ϕ, ϕ (tr), ΔG* and viscosity B-coefficient are calculated, the results show the existence of strong solute-solvent interactions.

Acknowledgments

Author wants to show her gratitude to the University for their assistance in this work.

Conflict of Interest

On behalf of all coauthors, I certify that all of the materials in this manuscript have no financial interest or non-financial interest with any organization, person, or any entity.

References

  1. Vemula, V. R.; Lagishetty, V.; Lingala, S. International Journal of Pharmaceutical Sciences Review and Research. 2010. 5(1), 41-51.
  2. Joshi, H. A.; Dyade, D. K.; Patil, R. N. Indo American Journal of Pharmaceutical Research. 2012, 2(11), 1387-1392.
  3. Kumar, H.; Kaur, K. Journal of molecular Liquids. 2012, 173, 130-136.
    CrossRef
  4. Dhondge, S. S.; Zoadape, S. P.; Parwate, D. V. Journal of Chemical Thermodynamics. 2012, 48, 207-212.
    CrossRef
  5.  Ryshetti, S.; Gupta, A.; Tangeda, S. J.; Gardas, R. L. Journal of Chemical Thermodynamics. 2014, 77, 123-130.
    CrossRef
  6. Aswala, S. R.; Aswale, S. S.; Hajares, S. J. Chem. Pharm. Res. 2012, 4(8), 3783-3791.
  7. Khanuja, P.; Chourey, V. R.; Hajares, S. J. Chem. Pharm. Res. 2012, 4(6), 3047-3050.
  8. The Merck Index: An Encycolopedia of Chemicals, Drugs and Biologicals, Merch and Co., Whitehouse Station, NJ, USA, 1989, 11th edition.
  9. Hegde, R. N.; Kumara Swamy, B. E.; Sherigara, B. S.; Nandibewoors, S. T. International Journal of Electrochemical Science. 2008.  3(3), 302-314.
  10. Indian Pharmacopoeia, Ministry of Health and Family, Welfare Government of India, Newdelh, 4th edition, 1996.
  11. British Pharmacopoeia, 30th edition, London, 1993, p. 55, 58, 370, 554.
  12. Karkowiak, J.; Journal of Chemical Thermodynamics. 2011, 43, 882-894.
    CrossRef
  13. Brahman, D.; Sinha, B. Journal of Chemical and Engineering Data. 2011, 56, 3073-3082.
  14. Brahman, D.; Sinha, B. Journal of Chemical Thermodynamics. 2014, 68, 260-269.
    CrossRef
  15. Masson, D. D. Philosophical Magazine. 1929, 8, 218-235.
    CrossRef
  16. Feakins, D.; Freemantle, D. J.; Lawrence, K. J. Chem. Soc. Faraday Trans. 1974, 1, 795.
    CrossRef
  17. Jones, G.; Dole, M. J. Am. Chem. Soc. 1929, 51, 2950-2964.
    CrossRef
  18. Sinha, B.; Sarkar, A.; Roy, P. K.; Brahman, D. International Journal of Thermodynamics. 2011, 32, 2062-2078.
    CrossRef


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.